This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gilbert’s Syndrome is an inherited condition that affects the liver. It is caused by an enzyme deficiency which results in the body having difficulty breaking down a certain type of waste product, bilirubin. It is the most common genetic disorder of the liver and is estimated to affect up to 7% of the population. People with Gilbert’s Syndrome often experience mild jaundice (yellowing of the skin and whites of the eyes), fatigue, abdominal discomfort, and nausea. These symptoms may become worse when a person is feeling stressed or is ill. A diagnosis is usually made when a blood test reveals elevated levels of unconjugated bilirubin. While Gilbert’s Syndrome is typically harmless, there are a few potential complications that should be monitored. People with Gilbert’s Syndrome may have an increased risk of developing gallstones and should be monitored for this issue. Additionally, those with Gilbert’s Syndrome may have an increased risk of developing liver cancer or other liver-related problems. Fortunately, there is no treatment necessary for Gilbert’s Syndrome and most people with the condition lead normal, healthy lives. However, it is important to maintain good health habits such as eating a balanced diet and getting regular exercise. Additionally, avoiding alcohol and drugs is recommended. In conclusion, Gilbert’s Syndrome is a common and harmless condition that affects the liver. While there is no treatment necessary, it is important to monitor for potential complications and to practice good health habits such as eating a healthy diet and exercising regularly.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States